(Q44083709)
Statements
Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study (English)
Scott R Evans
Susan E Krown
Marcia A Testa
Jamie H Von Roenn